Socioeconomic burden of hereditary angioedema: Results from the hereditary angioedema burden of illness study in Europe

Orphanet Journal of Rare Diseases

Volumn 9, Issue 1, 2014, Pages

  Aygören Pürsün, Emel ^a   Bygum, Anette ^b   Beusterien, Kathleen ^c   Hautamaki, Emily ^c   Sisic, Zlatko ^d   Wait, Suzanne ^e   Boysen, Henrik B ^f   Caballero, Teresa ^g  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c ICON PLC   (United Kingdom)

^d ViroPharma Chatsworth House   (United Kingdom)

^e SHW Health Ltd   (United Kingdom)

^f HAEi International Patient Organization for C1 Inhibitor Deficiencies   (Denmark)

^g HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Burden of illness; Hereditary angioedema; Productivity; Resource utilization

Indexed keywords

ANDROGEN; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; TRANEXAMIC ACID;

ABSENTEEISM; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CAREGIVER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DENMARK; DISEASE SEVERITY; EMERGENCY CARE; EMERGENCY WARD; EUROPE; FEMALE; GERMANY; HEALTH CARE UTILIZATION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; PAIN; PATIENT ATTITUDE; SCHOOL ADMISSION; SOCIOECONOMICS; SPAIN; WORK; DRUG WITHDRAWAL; HEALTH CARE COST; SCHOOL; SOCIAL STATUS; UNSPECIFIED SIDE EFFECT; WORK ENVIRONMENT; COST OF ILLNESS; ECONOMICS;

ANGIOEDEMAS, HEREDITARY; COST OF ILLNESS; EUROPE; HUMANS; SOCIOECONOMIC FACTORS;

EID: 84905961564     PISSN: None     EISSN: 17501172     Source Type: Journal    
DOI: 10.1186/1750-1172-9-99     Document Type: Article

References (28)

1. Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients. Agostoni A, Cicardi M, Medicine 1992 71 206 215
2. Hereditary angioedema: the clinical syndrome and its management. Frank MM, Gelfand JA, Atkinson JP, Ann Intern Med 1976 84 580 593
3. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin: part I: classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. Caballero T, Baeza M, Cabanas R, Campos A, Cimbollek S, Gomez-Traseira C, Gonzalez-Quevedo T, Guilarte M, Jurado-Palomo J, Larco JI, Lopez-Serrano MC, Lopez-Trascasa M, Marcos C, Munoz-Caro JM, Pedrosa M, Prior N, Rubio M, Sala-Cunill A, J Investig Allergol Clin Immunol 2011 21 333 347
4. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Bork K, Meng G, Staubach P, Hardt J, Am J Med 2006 119 267 274 (Pubitemid 43255068)
5. Hereditary angio-oedema in Denmark: a nationwide survey. Bygum A, Br J Dermatol 2009 161 1153 1158
6. Clinical practice: hereditary angioedema: [Review] [53 refs]. Zuraw BL, N Engl J Med 2008 359 1027 1036
7. Hereditary angioedema. Cicardi M, Agostoni A, N Engl J Med 1996 334 1666 1667 (Pubitemid 26192529)
8. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Bork K, Hardt J, Schicketanz KH, Ressel N, Arch Intern Med 2003 163 1229 1235 (Pubitemid 36613077)
9. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. Bork K, Hardt J, Witzke G, J Allergy Clin Immunol 2012 130 692 697
10. Angioedema due to C1 inhibitor deficiency in 2010. Cicardi M, Zanichelli A, Intern Emerg Med 2010 5 481 486
11. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. Caballero T, Farkas H, Bouillet L, Bowen T, Gompel A, Fagerberg C, Bjokander J, Bork K, Bygum A, Cicardi M, De CC, Frank M, Gooi JHC, Longhurst H, Martinez-Saguer I, Nielsen EW, Obtulowitz K, Perricone R, Prior N, J Allergy Clin Immunol 2012 129 308 320
12. Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, Reshef A, Zuraw B, HAWK (Hereditary Angioedema International Working Group), Allergy 2012 67 147 157
13. Hereditary angioedema caused by C1-esterase inhibitor deficiency: a literature-based analysis and clinical commentary on prophylaxis treatment strategies. Gower RG, Busse PJ, Aygören-Pürsün E, Barakat AJ, Caballero T, Davis-Lorton M, Farkas H, Hurewitz DS, Jacobs JS, Johnston DT, Lumry W, Maurer M, World Allergy Organ J 2011 4 9 S21
14. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, Aygören-Pürsün E, Craig T, Binkley K, Hebert J, Ritchie B, Bouillet L, Betschel S, Cogar D, Dean J, Devaraj R, Hamed A, Kamra P, Keith PK, Lacuesta G, Leith E, Lyons H, Mace S, Mako B, Neurath D, Poon MC, Rivard GE, Schellenberg R, Rowan D, Rowe A, et al. Allergy Asthma Clin Immunol 2010 6 24
15. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin: part II: treatment, follow-up, and special situations. [Review][Erratum appears in J Investig Allergol Clin Immunol. 2012;22(2):3 p following 153]. Caballero T, Baeza ML, Cabanas R, Campos A, Cimbollek S, Gomez-Traseira C, Gonzalez-Quevedo T, Guilarte M, Jurado-Palomo J, Larco JI, Lopez-Serrano MC, Lopez-Trascasa M, Marcos C, Munoz-Caro JM, Pedrosa M, Prior N, Rubio M, Sala-Cunill A, Spanish Study Group on Bradykinin-Induced Angioedema (SGBA), J Investig Allergol Clin Immunol 2011 442 21 422 441
16. On demand treatment and home therapy of hereditary angioedema in Germany-the Frankfurt experience. Aygören-Pürsün E, Martinez-Saguer I, Rusicke E, Klingebiel T, Kreuz W, Allergy Asthma Clin Immunol 2010 6 21
17. Hereditary angioedema: an update on available therapeutic options: [Review]. Maurer M, Magerl M, J Dtsch Dermatol Ges 2010 8 663 672
18. Ruconest: summary of product characteristics. European Medicines Agency, 2010 http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product- Information/human/001223/WC500098542.pdf
19. Cinryze: summary of product characteristics. European Medicines Agency, 2011 http://www.ema.europa.eu/docs/en-GB/document-library/EPAR-Product- Information/human/001207/WC500108895.pdf
20. Descriptive epidemiology of hereditary angioedema emergency department visits in the United States, 2006-2007. Zilberberg MD, Nathanson BH, Jacobsen T, Tillotson G, Allergy Asthma Proc 2011 32 390 394
21. Economic costs associated with acute attacks and long-term management of hereditary angioedema. Wilson DA, Bork K, Shea EP, Rentz AM, Blaustein MB, Pullman WE, Ann Allergy Asthma Immunol 2010 104 314 320
22. The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe): background and methodology. Bygum A, Aygören- Pürsün E, Caballero T, Beusterien K, Gholizadeh S, Musingarimi P, Wait S, Boysen H, BMC Dermatol 2012 12 4
23. The humanistic burden of hereditary angioedema: results from the burden of illness study in Europe. Caballero T, Aygören-Pürsün E, Bygum A, Beusterien K, Hautamaki E, Sisic Z, Wait S, Boysen H, Allergy Asthma Proc 2014 35 1 47 53
24. The use and performance of productivity scales to evaluate presenteeism in mood disorders. [Review]. Despiegel N, Danchenko N, Francois C, Lensberg B, Drummond MF, Value Health 2012 15 1148 1161
25. Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden. Nordenfelt P, Dawson S, Wahlgren C-F, Lindfors A, Mallbris L, Björkander J, Allergy Asthma Proc 2014 35 185 190
26. Burden of disease in hospitalized RSV-positive children in Germany. Weigl JA, Puppe W, Rockahr S, Schmitt HJ, Klin Padiatr 2002 214 6 334 342 (Pubitemid 35446298)
27. Quality of life in patients with epidermylosis bullosa. Tabolli S, Sampogna F, Di Petro C, Paradisi A, Uras C, Zotti P, Castiglia D, Zambruno G, Abeni D, Br J Dermatol 2009 161 4 869 877
28. The humanistic burden of hereditary angioedema: Impact on health-related quality of life, productivity, and depression. Lumry WR, Castaldo AJ, Vernon MK, Blaustein MB, Wilson DA, Horn PT, Allergy Asthma Proc 2010 31 407 414